top of page

Skin Health Sensor

The Skin Health Sensor analyzes the genetically determined risk for skin cancer and recommends preventative measures.

Skin cancer requires early detection for better chances of healing. Skin cancer refers to various malignant skin diseases. The most well-known forms are basal cell and squamous cell carcinoma (together referred to as non-melanoma skin cancer) and the more dangerous malignant melanoma. Compared to other types of cancer, skin cancer is generally easy to diagnose and treat if detected early. However, tumors often develop unnoticed and only cause symptoms once cancer has already spread.

Symptoms can vary widely. For example, malignant melanoma can appear as a dark, irregular, flat, or nodular spot on the skin, while basal cell carcinoma can present as a waxy lump that alternately bleeds and heals or dark ulcers.

For these reasons, regular skin cancer screening is recommended to diagnose skin cancer early and initiate any necessary treatment. Depending on the type and stage of the disease, treatment options can include surgery, radiation therapy, chemotherapy, photodynamic therapy, or immunotherapy.

Risk factors for skin cancer Excessive UV radiation is a major trigger for skin cancer, which is why outdoor workers are especially at risk. Skin cancer is even recognized as an occupational disease in the construction industry. Other risk factors include exposure to chemicals and, in rare types of skin cancer (such as Kaposi's sarcoma), viral infections.

In addition, genetic factors also play a significant role in our individual risk of developing skin cancer. Therefore, an analysis of relevant genetic variations can help prevent the development of skin cancer.

How does our Skin Health Sensor work? With our Skin Health Sensor, our laboratory examines the submitted saliva sample for 18 genetic variants that may increase the risk of developing white or black skin cancer.

This genetic test allows us to determine an individual's risk of skin cancer and assess the impact of their genetic profile on the effectiveness of 27 common medications.

We analyze the test results in a comprehensive report that also provides specific recommendations for prevention.

In this way, our Skin Health Sensor can help genetically predisposed patients reduce their risk of skin cancer and diagnose any potential illness early.

Skin Health Sensor Overview
  • Analysis of 18 relevant genetic variations

  • Assessment of genetically determined skin cancer risk

  • Evaluation of the effectiveness of 27 medications based on a genetic profile

  • Reliable testing procedure in our laboratory

  • A written report of the results Individual recommendations for prevention

bottom of page